World Top 100 Biopharmaceutical Companies List by Market Cap as of August 2026

World Top 100 Biopharmaceutical Companies List by Market Cap as of August 2026, World Biggest 100 Biopharmaceutical Companies by Market Cap, World Largest 100 Biopharmaceutical Companies in the World by market cap as of August 2026.

World Top Biopharmaceutical Companies 2026
World Largest Biopharmaceutical Companies by Market Cap in 2026, World Top Biopharmaceutical Companies by Market Cap in 2026.

  1. UCB SA

    World Rank (Aug-2026)
    533
    Market Cap (Aug-2026)
    48.562 Billion USD
    World Rank (Jan-05-2024)
    1,055
    Market Cap (Jan-05-2024)
    16.926 Billion USD
    World Rank (Jul-30-2023)
    1,073
    Market Cap (Jul-30-2023)
    17.074 Billion USD
    World Rank (Dec-25-2022)
    1,081
    Market Cap (Dec-25-2022)
    15.163 Billion USD
    World Rank (Jan-07-2022)
    1,006
    Market Cap (Jan-07-2022)
    20.61 Billion USD
    Annual Revenue in USD
    6,083 Million USD
    Annual Operating Income in USD
    773 Million USD
    Annual Net Income in USD
    461 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Belgium
    CEO
    Jean-Christophe Tellier
    Stock Category
    EURONEXT 100
    S&P EUROPE 350
    Yahoo @ Brussels
    Company Profile
    UCB is a global biopharmaceutical company focusing on creating value for people living with neurology and immunology conditions. Headquartered in Brussels, Belgium. As on 2019, UCB has Total revenue of 4.9 billion EUR and has more than 7,600 employees.
    Company Website
    UCB
    Wikipedia
    Wikipedia

  2. BeiGene Ltd.

    World Rank (Aug-2026)
    620
    Market Cap (Aug-2026)
    42.578 Billion USD
    World Rank (Jan-05-2024)
    1,052
    Market Cap (Jan-05-2024)
    17.087 Billion USD
    World Rank (Jul-30-2023)
    812
    Market Cap (Jul-30-2023)
    23.146 Billion USD
    World Rank (Dec-25-2022)
    710
    Market Cap (Dec-25-2022)
    23.788 Billion USD
    World Rank (Jan-07-2022)
    898
    Market Cap (Jan-07-2022)
    23.27 Billion USD
    Annual Revenue in USD
    1,415 Million USD
    Annual Operating Income in USD
    -1,789 Million USD
    Annual Net Income in USD
    -2,003 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Cayman Islands
    Yahoo @ HongKong
    Company Profile

    Bio Pharmaceutical Company with headquarters is in Cayman Islands.

    Company Website
    BEIGENE LTD.

  3. Celltrion

    World Rank (Aug-2026)
    794
    Market Cap (Aug-2026)
    33.137 Billion USD
    World Rank (Jan-05-2024)
    509
    Market Cap (Jan-05-2024)
    35.824 Billion USD
    World Rank (Jul-30-2023)
    1,134
    Market Cap (Jul-30-2023)
    16.020 Billion USD
    World Rank (Dec-25-2022)
    883
    Market Cap (Dec-25-2022)
    18.618 Billion USD
    World Rank (Jan-07-2022)
    985
    Market Cap (Jan-07-2022)
    21.21 Billion USD
    Annual Revenue in USD
    1,793 Million USD
    Annual Operating Income in USD
    508 Million USD
    Annual Net Income in USD
    422 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    South Korea
    CEO
    Hyoung Ki Kim
    Yahoo @ SouthKorea
    Company Profile

    Celltrion is a Biopharmaceutical company. The headquarters is in South Korea.

    Celltrion achieved what was thought impossible by launching the world’s first “antibody biosimilar” from a country with a relatively underdeveloped pharmaceutical sector. The company has pioneered numerous uncharted areas to stellar success, which it plans to follow up by continuing its growth as a global biopharmaceutical company with unique approaches to small molecule pharmaceuticals and new businesses such as the Ubiquitous-healthcare platform business.

    Company Website
    Celltrion
    Wikipedia
    Wikipedia

  4. Novozymes A/S

    World Rank (Aug-2026)
    801
    Market Cap (Aug-2026)
    32.823 Billion USD
    World Rank (Jan-05-2024)
    1,197
    Market Cap (Jan-05-2024)
    14.692 Billion USD
    World Rank (Jul-30-2023)
    1,283
    Market Cap (Jul-30-2023)
    13.844 Billion USD
    World Rank (Dec-25-2022)
    1,165
    Market Cap (Dec-25-2022)
    13.689 Billion USD
    World Rank (Jan-07-2022)
    959
    Market Cap (Jan-07-2022)
    21.91 Billion USD
    Annual Revenue in USD
    2,595 Million USD
    Annual Operating Income in USD
    655 Million USD
    Annual Net Income in USD
    543 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Denmark
    CEO
    Ester Baiget
    Stock Category
    S&P EUROPE 350
    Yahoo @ Copenhagen
    Company Profile

    Novozymes is a Biotechnology and Pharmaceutical company with headquarters is in Denmark.

    Facts About Company

    For year ending Dec-2022, Novozymes annual revenue was 17,553 million DKK and EBITDA was 6,046 million DKK and net profit was 3,686 million DKK.

    As on December-2022, Novozymes had 6,700 employees.

    Company Website
    NOVOZYMES A/S
    Wikipedia
    Wikipedia

  5. Alnylam Pharmaceuticals

    World Rank (Aug-2026)
    855
    Market Cap (Aug-2026)
    30.595 Billion USD
    World Rank (Jan-05-2024)
    763
    Market Cap (Jan-05-2024)
    24.134 Billion USD
    World Rank (Jul-30-2023)
    762
    Market Cap (Jul-30-2023)
    24.817 Billion USD
    World Rank (Dec-25-2022)
    578
    Market Cap (Dec-25-2022)
    29.268 Billion USD
    World Rank (Jan-07-2022)
    1,156
    Market Cap (Jan-07-2022)
    17.72 Billion USD
    Annual Revenue in USD
    3,714 Million USD
    Annual Operating Income in USD
    502 Million USD
    Annual Net Income in USD
    314 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    CEO
    John Maraganore
    Stock Category
    Nasdaq 100
    Yahoo @ Nasdaq
    Company Profile

    ALNYLAM PHARMACEUTICALS is Biopharmaceutical company with headquarters is in Massachusetts, USA.ALNYLAM leaders from the biopharmaceutical industry, bringing together their experiences of drug discovery, drug development, and commercialization.Alnylam has led the translation of RNAi (RNA interference) from Nobel Prize-winning discovery into an innovative, entirely new class of medicines.

    Company Website
    ALNYLAM PHARMACEUTICALS INC
    Wikipedia
    Wikipedia

  6. Insmed

    World Rank (Aug-2026)
    945
    Market Cap (Aug-2026)
    27.023 Billion USD
    World Rank (Jan-05-2024)
    3,388
    Market Cap (Jan-05-2024)
    4.167 Billion USD
    World Rank (Jul-30-2023)
    4,448
    Market Cap (Jul-30-2023)
    2.913 Billion USD
    World Rank (Dec-25-2022)
    4,526
    Market Cap (Dec-25-2022)
    2.621 Billion USD
    World Rank (Jan-07-2022)
    4,793
    Market Cap (Jan-07-2022)
    3.05 Billion USD
    Annual Revenue in USD
    606 Million USD
    Annual Operating Income in USD
    -1,247 Million USD
    Annual Net Income in USD
    -1,277 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Insmed is a Biopharmaceutical company. The headquarters is in USA.

    Company Website
    INSMED INC

  7. Roivant Sciences

    World Rank (Aug-2026)
    983
    Market Cap (Aug-2026)
    26.148 Billion USD
    World Rank (Jan-05-2024)
    1,854
    Market Cap (Jan-05-2024)
    8.727 Billion USD
    World Rank (Jul-30-2023)
    2,004
    World Rank (Dec-25-2022)
    2,004
    World Rank (Jan-07-2022)
    2,069
    Annual Revenue in USD
    55 Million USD
    Annual Net Income in USD
    -845 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
    Switzerland
    Company Profile

    Roivant Sciences is biopharmaceutical and health technology companies. Headquarters is in Switzerland. 

    Company Website
    ROIVANT SCIENCES
    Wikipedia
    Wikipedia

  8. Wuxi Biologics (Cayman)

    World Rank (Aug-2026)
    986
    Market Cap (Aug-2026)
    26.042 Billion USD
    World Rank (Jan-05-2024)
    1,181
    Market Cap (Jan-05-2024)
    14.971 Billion USD
    World Rank (Jul-30-2023)
    804
    Market Cap (Jul-30-2023)
    23.456 Billion USD
    World Rank (Dec-25-2022)
    579
    Market Cap (Dec-25-2022)
    29.224 Billion USD
    World Rank (Jan-07-2022)
    456
    Market Cap (Jan-07-2022)
    43.63 Billion USD
    Annual Revenue in USD
    2,136 Million USD
    Annual Operating Income in USD
    671 Million USD
    Annual Net Income in USD
    618 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    China
    Yahoo @ Hong Kong
    Company Profile

    WuXi Biologics is a biotechnology company related to global Contract Research, Development and manufacturing offering end-to-end solutions that enable partners to discover, develop and manufacture biologics.  Headquarters is in China.

    Company Website
    WuXi Biologics
    Wikipedia
    Wikipedia

  9. Moderna

    World Rank (Aug-2026)
    1,016
    Market Cap (Aug-2026)
    25.280 Billion USD
    World Rank (Jan-05-2024)
    436
    Market Cap (Jan-05-2024)
    41.430 Billion USD
    World Rank (Jul-30-2023)
    397
    Market Cap (Jul-30-2023)
    45.234 Billion USD
    World Rank (Dec-25-2022)
    174
    Market Cap (Dec-25-2022)
    76.483 Billion USD
    World Rank (Jan-07-2022)
    188
    Market Cap (Jan-07-2022)
    86.71 Billion USD
    Annual Revenue in USD
    1,944 Million USD
    Annual Operating Income in USD
    -3,074 Million USD
    Annual Net Income in USD
    -2,822 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    CEO
    Stephane Bancel
    Stock Category
    S&P 500
    Yahoo @ Nasdaq
    Company Profile

    Moderna is Biotechnology sector company with headquarters is in Massachusetts, USA. It has done good work on Covid-19 vaccine.

    As on 2022, Moderna has 3,900 employees.

    Moderna annual revenue generated for period ending Dec-2022 was 18.87 billion USD.

    Moderna annual net income generated for period ending Dec-2022 was 8.36 billion USD.

    Moderna annual revenue generated for period ending Dec-2021 was 16,471 million USD.

    Company Website
    MODERNA
    Wikipedia
    Wikipedia

  10. Incyte Corporation

    World Rank (Aug-2026)
    1,044
    Market Cap (Aug-2026)
    24.356 Billion USD
    World Rank (Jan-05-2024)
    1,185
    Market Cap (Jan-05-2024)
    14.923 Billion USD
    World Rank (Jul-30-2023)
    1,265
    Market Cap (Jul-30-2023)
    14.075 Billion USD
    World Rank (Dec-25-2022)
    918
    Market Cap (Dec-25-2022)
    18.101 Billion USD
    World Rank (Jan-07-2022)
    1,253
    Market Cap (Jan-07-2022)
    16.17 Billion USD
    Annual Revenue in USD
    5,141 Million USD
    Annual Operating Income in USD
    1,515 Million USD
    Annual Net Income in USD
    1,287 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    CEO
    Herve Hoppenot
    Stock Category
    S&P 500
    Yahoo @ Nasdaq
    Company Profile

    Incyte Corporation is a Bio-Pharmaceutical company with headquarters is in Delaware, USA.

    As on 2021, Incyte Corporation has 2,094 employees, 989 are in research and development, 187 in medical affairs, 638 in sales and marketing and 280 in operations support, finance and administrative positions.

    As on 2022, Incyte Corporation has 2,324 employees.

    Incyte Corporation annual revenue generated for period ending Dec-2022 was 3,394 million USD.

    Company Website
    Incyte Corporation - Pharmaceutical Company
    Wikipedia
    Wikipedia

Share